Vimian Group AB (publ)
VIMIAN
Rank in Stocks
#5509
Vimian Group AB (publ) operates as a global enterprise in the animal health... Vimian Group AB (publ) operates as a global enterprise in the animal health sector, segmenting its business into Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. Through its Nextmune brand, the company delivers a comprehensive portfolio of proprietary diagnostic tools and both prescription and non-prescription therapies designed for the preventive care and ongoing management of chronic conditions in companion animals. The Indical Bioscience division provides specialized molecular and immunodiagnostic solutions, predominantly employed by laboratories for veterinary-specific applications across both livestock and companion animal health markets. Additionally, the VetFamily brand runs a membership-based platform that furnishes veterinary clinics with crucial procurement services, technology-enabled operational support (including online marketing, education, and human resources), and fosters a professional community. Finally, Movora is responsible for supplying orthopedic implants to veterinarians and academic institutions. Founded in 2020, Vimian Group's headquarters are located in Stockholm, Sweden.
Share Price
$4.30
Last synced: 2026-11-09
Market Cap
$2.26B
Change (1 day)
1.16%
Change (1 year)
29.96%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Vimian Group AB (publ) (VIMIAN)
Category
Healthcare
EPS for Vimian Group AB (publ) (VIMIAN)
EPS as of September 2026 TTM: $0.08
According to Vimian Group AB (publ)'s latest financial reports, its current EPS (TTM) is $0.08. At the end of 2025 the company had an EPS of $0.07, an increase over its 2024 EPS of $0.04.
EPS history for Vimian Group AB (publ) from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.08 | 18.14% |
| 2025 | $0.07 | 84.29% |
| 2024 | $0.04 | 59.17% |
| 2023 | $0.02 | -225.00% |
| 2022 | $-0.02 | -184.58% |
| 2021 | $0.02 | -86.69% |
| 2020 | $0.17 | -4,836.11% |
| 2019 | 0.00 | 56.52% |
| 2018 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | 22,862.52% |
US
|
|
| $6.12 | 7,300.24% |
US
|
|
| $1.38 | 1,565.18% |
CN
|
|
| $14.83 | 17,832.29% |
US
|
|
| $5.09 | 6,054.78% |
US
|
Questions about Vimian Group AB (publ)'s earnings per share (EPS)
What is Vimian Group AB (publ)'s earnings per share (EPS)?
Vimian Group AB (publ)'s earnings per share (EPS) over the last twelve months is $0.08, as of Sep 2026.
What was Vimian Group AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Vimian Group AB (publ)'s earnings per share (EPS) was $0.07, 75.00% more than in 2024 ($0.04).
How has Vimian Group AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Vimian Group AB (publ)'s earnings per share (EPS) went from $0.17 to $0.07, an average decline of 16.26% a year.
How does Vimian Group AB (publ)'s earnings per share (EPS) compare with similar companies?
Vimian Group AB (publ)'s earnings per share (EPS) ($0.08) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.